Orion Corporation, Orion Pharma

🇫🇮Finland

Country: 🇫🇮Finland

Ownership: -

Employees: -

Market Cap: -

Website

Clinical Trials

Pharmacokinetic Study Comparing Tiotropium Easyhaler and Spiriva Handihaler

Phase 1

Completed

Conditions: Healthy Subjects

Interventions: Drug: Tiotropium Bromide Monohydrate

First Posted Date: 2018-01-17

Last Posted Date: 2018-06-14

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 24

Registration Number: NCT03400241

Locations: 🇫🇮
Clinical Pharmacology Unit, Espoo, Finland

Impact of Changing the Dosing Regimen on the PK Profile of ODM-203

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: ODM-203 (Period 1)
Drug: ODM-203 (Period 2)
Drug: ODM-203 (Periods 3-6)

First Posted Date: 2017-08-07

Last Posted Date: 2019-05-14

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 16

Registration Number: NCT03240445

Locations: 🇬🇧
Quotient Clinical Ltd, Nottingham, United Kingdom

Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus (SAIMI)

Phase 1

Completed

Conditions: Asthma

Interventions: Drug: salmeterol-fluticasone

First Posted Date: 2017-08-03

Last Posted Date: 2018-04-06

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 64

Registration Number: NCT03238482

Locations: 🇫🇮
Clinical Pharmacology Unit, Orion Pharma, Espoo, Finland

Pharmacokinetic of Levodopa Study in Healthy Males

Phase 1

Completed

Conditions: Parkinson Disease

Interventions: Drug: Levodopa, carbidopa, ODM-104

First Posted Date: 2017-05-04

Last Posted Date: 2017-09-26

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 20

Registration Number: NCT03140956

Locations: 🇫🇮
Clinical Pharmacology Unit, Orion Pharma, Espoo, Finland

Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Phase 1

Completed

Conditions: Asthma

Interventions: Drug: Budesonide/formoterol
Other: Charcoal
Drug: Symbicort Turbuhaler

First Posted Date: 2017-03-08

Last Posted Date: 2017-03-08

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 20

Registration Number: NCT03073057

Locations: 🇫🇮
Orion Pharma, Clinical Pharmacology Unit, Espoo, Finland

Pharmacokinetic Study Comparing Salmeterol/Fluticasone Easyhaler and Seretide Diskus

Phase 1

Completed

Conditions: Asthma

Interventions: Drug: Salmeterol/fluticasone Easyhaler with charcoal
Drug: Seretide Diskus
Drug: Salmeterol/fluticasone Easyhaler
Drug: Seretide Diskus with charcoal

First Posted Date: 2017-02-23

Last Posted Date: 2017-03-03

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 64

Registration Number: NCT03060044

Locations: 🇫🇮
Orion Pharma pharmacology Unit, Espoo, Finland

Dose-finding Pharmacokinetic Study in Healthy Males

Phase 1

Completed

Conditions: Healthy Volunteers

Interventions: Drug: Levodopa
Drug: Carbidopa
Drug: ODM-104

First Posted Date: 2017-02-16

Last Posted Date: 2021-05-27

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 56

Registration Number: NCT03055936

Locations: 🇩🇪
Nuvisan Pharma Services, Neu-Ulm, Germany

ODM-207 in Patients With Advance Solid Tumours

Phase 1

Completed

Conditions: Solid Tumors

Interventions: Drug: ODM-207

First Posted Date: 2017-01-30

Last Posted Date: 2019-10-15

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 36

Registration Number: NCT03035591

Locations: 🇫🇮
Helsinki University Central Hospital, Department of Oncology, Helsinki, Finland

Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)

Phase 2

Completed

Conditions: Parkinson's Disease

Interventions: Drug: Stalevo
Drug: levodopa MR

First Posted Date: 2016-05-06

Last Posted Date: 2018-04-05

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 84

Registration Number: NCT02764125

Locations: 🇱🇻
Investigator, Riga, Latvia
🇫🇮
Clinical Research Services Turku CRST, Turku, Finland
🇩🇪
Study Coordinating Investigator, Harleshausen, Kassel, Germany

and more 1 locations

Pharmacokinetic Study in Healthy Volunteers

Phase 1

Completed

Conditions: Parkinson's Disease

Interventions: Drug: levodopa, carbidopa, ODM-104
Drug: levodopa, carbidopa, entacapone

First Posted Date: 2015-09-18

Last Posted Date: 2016-01-14

Lead Sponsor: Orion Corporation, Orion Pharma

Target Recruit Count: 15

Registration Number: NCT02554734

Locations: 🇫🇮
Clinical Research Services Turku CRST, Turku, Finland

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy